Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Lung Cancer

Durvalumab for Treatment of Lung Cancer

Posted on November 27, 2023
Post Views: 582

Lung CancerDurvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected into a vein over 60 minutes and is usually injected once every two weeks, once every three weeks or once every four weeks for as long as doctor recommends. The dosing schedule also depends on cancer type and how the body responds to the medication.

It is used alone to treat non-small cell lung cancer that has spread to nearby tissues and cannot be removed by surgery. It is also used in combination with platinum-based chemotherapy and Imjudo to treat a certain type of non-small cell lung cancer that has spread throughout the lungs and to other parts of the body as well. Its injection is also used in combination with chemotherapy agents to treat small cell lung cancer in adults.

Durvalumab has the capacity to prolong survival in people with advanced small cell lung cancer, according to the new results from clinical trail show. In this study, they combined treatment with Durvalumab to standard chemotherapy regimen to increase the overall survival rates in patients with newly diagnosed advanced small cell lung cancer by approximately three months in comparison to those with standard chemotherapy alone. Unfortunately, SCLC tends to spread, come back and when it comes back, it is less sensitive to subsequent chemotherapy.

Further studies are recommended to identify patients with small cell lung cancer who might derive long-term survival benefit from Durvalumab. There’s still lot of room for improvement in SCLC treatment and clinical trial strategies are coming through the pipeline.

The information shared in this blog is for educational purposes only. For any medical issues, you should always contact your healthcare provider.

Subscribe to our newsletter or follow us on Facebook or Twitter today and never miss out an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,324)
  • Lung Cancer: Symptoms and Treatment (5,656)
  • What is Non-Small-Cell Lung Cancer? (5,552)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Study: Wildfire Smoke Exposure Affects Lung Cancer Survival June 2, 2025
  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d